American Board of Nuclear Medicine

American Board of Nuclear Medicine
FoundedJuly 28, 1971; 53 years ago (1971-07-28)[1]
13-2690306[2]
Legal status501(c)(3) nonprofit organization[3]
HeadquartersSt. Louis, Missouri[2]
Joanna Fair, M.D., Ph.D.[4]
George Segall, M.D.[4]
Revenue (2015)
$1,098,897[2]
Expenses (2015)$925,158[2]
Websitewww.abnm.org

The American Board of Nuclear Medicine (ABNM) certifies physicians as specialists in the practice of nuclear medicine. Diplomates of the ABNM are called nuclear medicine physicians. The ABNM is one of the 24 member boards of the American Board of Medical Specialties (ABMS).

Nuclear medicine procedures use the tracer principle, most often radioactive tracers called radiopharmaceuticals, to evaluate molecular, metabolic, physiologic, and pathologic conditions for diagnosis, therapy, and research. Nuclear medicine procedures are the major clinical applications of molecular imaging and molecular therapy.

  1. ^ "The American Board of Nuclear Medicine, Inc." Division of Corporations. Delaware Department of State. Retrieved October 14, 2017.
  2. ^ a b c d "Form 990: Return of Organization Exempt from Income Tax". American Board of Nuclear Medicine. Guidestar. December 31, 2015.
  3. ^ "American Board of Nuclear Medicine Inc." Exempt Organization Select Check. Internal Revenue Service. Retrieved October 14, 2017.
  4. ^ a b "Board Members". American Board of Nuclear Medicine. Retrieved February 2020.